{"id":"https://openalex.org/W2000819438","doi":"https://doi.org/10.1016/s1470-2045(14)71184-2","title":"IBIS-I tamoxifen update: maturity brings questions","display_name":"IBIS-I tamoxifen update: maturity brings questions","publication_year":2014,"publication_date":"2014-12-11","ids":{"openalex":"https://openalex.org/W2000819438","doi":"https://doi.org/10.1016/s1470-2045(14)71184-2","mag":"2000819438","pmid":"https://pubmed.ncbi.nlm.nih.gov/25497695"},"language":"en","primary_location":{"id":"doi:10.1016/s1470-2045(14)71184-2","doi":"https://doi.org/10.1016/s1470-2045(14)71184-2","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1470-2045(14)71184-2","pdf_url":"http://www.thelancet.com/article/S1470204514711842/pdf","source":{"id":"https://openalex.org/S116900674","display_name":"The Lancet Oncology","issn_l":"1470-2045","issn":["1470-2045","1474-5488"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.thelancet.com/article/S1470204514711842/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004840750","display_name":"Rowan T. Chlebowski","orcid":"https://orcid.org/0000-0002-4212-6184","observed_orcids":["https://orcid.org/0000-0002-4212-6184"]},"institutions":[{"id":"https://openalex.org/I177607063","display_name":"The Lundquist Institute","ror":"https://ror.org/025j2nd68","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I177607063"]},{"id":"https://openalex.org/I4210165985","display_name":"Harbor\u2013UCLA Medical Center","ror":"https://ror.org/05h4zj272","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328359107","https://openalex.org/I4210165985"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rowan T Chlebowski","raw_affiliation_strings":["Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center, 1024 W Carson Street, Torrance, CA 90502, USA. Electronic address: rowanchlebowski@gmail.com","Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center, 1024 W Carson Street, Torrance, CA 90502, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center, 1024 W Carson Street, Torrance, CA 90502, USA. Electronic address: rowanchlebowski@gmail.com","institution_ids":["https://openalex.org/I177607063","https://openalex.org/I4210165985"]},{"raw_affiliation_string":"Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center, 1024 W Carson Street, Torrance, CA 90502, USA","institution_ids":["https://openalex.org/I177607063","https://openalex.org/I4210165985"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5004840750"],"corresponding_institution_ids":["https://openalex.org/I177607063","https://openalex.org/I4210165985"],"apc_list":{"value":7280,"currency":"USD","value_usd":7280},"apc_paid":{"value":7280,"currency":"USD","value_usd":7280},"fwci":1.0917,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.76387,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"16","issue":"1","first_page":"7","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.5508000254631042,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.5508000254631042,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12103","display_name":"Cancer Risks and Factors","score":0.1316000074148178,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.08919999748468399,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":1.0},{"id":"https://openalex.org/keywords/breast-cancer-chemoprevention","display_name":"breast cancer chemoprevention","score":0.9810000061988831},{"id":"https://openalex.org/keywords/high-risk-women","display_name":"high-risk women","score":0.9340000152587891},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.9580000042915344},{"id":"https://openalex.org/keywords/breast-cancer-risk-reduction","display_name":"breast cancer risk reduction","score":0.4749999940395355}],"concepts":[{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.8376598954200745},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8221923112869263},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.8084917068481445},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.5307122468948364},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5067985653877258},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4818381071090698},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.45428702235221863},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4251739978790283},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38120314478874207},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D002285","descriptor_name":"Carcinoma, Intraductal, Noninfiltrating","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016588","descriptor_name":"Anticarcinogenic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s1470-2045(14)71184-2","doi":"https://doi.org/10.1016/s1470-2045(14)71184-2","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1470-2045(14)71184-2","pdf_url":"http://www.thelancet.com/article/S1470204514711842/pdf","source":{"id":"https://openalex.org/S116900674","display_name":"The Lancet Oncology","issn_l":"1470-2045","issn":["1470-2045","1474-5488"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Oncology","raw_type":"journal-article"},{"id":"pmid:25497695","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25497695","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet. Oncology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/s1470-2045(14)71184-2","doi":"https://doi.org/10.1016/s1470-2045(14)71184-2","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s1470-2045(14)71184-2","pdf_url":"http://www.thelancet.com/article/S1470204514711842/pdf","source":{"id":"https://openalex.org/S116900674","display_name":"The Lancet Oncology","issn_l":"1470-2045","issn":["1470-2045","1474-5488"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Lancet Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2000819438.pdf","grobid_xml":"https://content.openalex.org/works/W2000819438.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W1989261524","https://openalex.org/W1993066694","https://openalex.org/W2014709804","https://openalex.org/W2037056094","https://openalex.org/W2070541537","https://openalex.org/W2096913799","https://openalex.org/W2099535971","https://openalex.org/W2118728607","https://openalex.org/W2146454566","https://openalex.org/W2161387798","https://openalex.org/W2169666080"],"related_works":["https://openalex.org/W2161387798","https://openalex.org/W7098080793","https://openalex.org/W2341333575","https://openalex.org/W2277236992","https://openalex.org/W2044000797","https://openalex.org/W1970161486","https://openalex.org/W2090511345","https://openalex.org/W1969159964","https://openalex.org/W4235448197","https://openalex.org/W1530442957"],"abstract_inverted_index":{"The":[0,37,48],"International":[1],"Breast":[2],"cancer":[3],"Intervention":[4],"Study":[5],"(IBIS-I)":[6],"is":[7,40,68],"a":[8,20],"randomised,":[9],"placebo-controlled":[10],"chemoprevention":[11],"clinical":[12],"trial":[13],"of":[14,17,22,27,44,50,62],"the":[15,45],"effects":[16],"tamoxifen":[18],"in":[19,36],"population":[21],"women":[23],"at":[24],"high":[25],"risk":[26],"developing":[28],"breast":[29],"cancer.":[30],"Jack":[31],"Cuzick":[32],"and":[33],"colleagues'":[34],"report":[35],"Lancet":[38],"Oncology1":[39],"an":[41],"important":[42],"update":[43],"IBIS-I":[46],"trial.":[47],"achievement":[49],"such":[51],"long-term":[52],"follow-up":[53],"(median":[54],"16":[55],"years),":[56],"especially":[57],"with":[58],"more":[59],"than":[60],"74%":[61],"participants":[63],"remaining":[64],"masked":[65],"to":[66],"randomisation,":[67],"commendable.":[69]},"counts_by_year":[{"year":2024,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}